MedTrace Logo

Unrestricted Rehabilitation Pathway Following Total Hip Replacement

NCT03833258 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2022-11-18

No results posted yet for this study

Summary

The purpose of ReHip2 is to explore the impact on function and quality of life in patients following Total Hip Replacement (THR). A randomised controlled trial will compare two different rehabilitation pathways following surgery (Routine care with precautions and Treatment group with no precautions). The proposal is to carry out the RCT with a minimum of 182 patients based in the UK.

Conditions

  • Total Hip Replacement

Interventions

BEHAVIORAL

Rehabilitation with no precautions

Patients will recover from total hip replacement surgery being guided by pain only and not by the precautions imposed upon them by clinicians.

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Principal Investigators

  • JACQUELINE OLDHAM · University of Manchester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-22
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03833258 on ClinicalTrials.gov